New pill targets cancer's repair system in advanced tumors
NCT ID NCT05898399
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tests a new oral drug called ART6043, which blocks a DNA repair protein in cancer cells. It is given alone or with olaparib to adults with advanced or metastatic solid tumors that have not responded to other treatments. The goal is to see if it is safe and can shrink or slow tumor growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clínico Universitario de Valladolid
RECRUITINGValladolid, Castille and León, 47003, Spain
-
Hospital San Pedro de Alcántara
RECRUITINGCáceres, Extremadura, 10003, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Madrid, 28041, Spain
-
Hospital Universitario Clínico San Cecilio
RECRUITINGGranada, Andalusia, 18007, Spain
-
Hospital de la Santa Creu i Sant Pau
RECRUITINGBarcelona, Catalonia, 08025, Spain
-
Jefferson University Hospitals - Kimmel Cancer Center
ACTIVE_NOT_RECRUITINGPhiladelphia, Pennsylvania, 17107, United States
-
Mary Crowley Cancer Center - Clinic
COMPLETEDDallas, Texas, 75251, United States
-
Memorial Sloan-Kettering Cancer Center (MSKCC)
ACTIVE_NOT_RECRUITINGNew York, New York, 10065-6800, United States
-
SCRI oncology partners
COMPLETEDNashville, Tennessee, 37203, United States
-
South Texas Accelerated Research Therapeutics (START) - Midwest
ACTIVE_NOT_RECRUITINGGrand Rapids, Michigan, 49546, United States
-
Stephenson Cancer Center - Oncology
ACTIVE_NOT_RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
The University of Texas - MD Anderson Cancer Center
ACTIVE_NOT_RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.